These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19209416)

  • 1. [Vestibo in the treatment of cochleovestibular disorders].
    Kunel'skaia NL; Levina IuV; Doronina OM; Krasiuk AA; Izotova GN
    Vestn Otorinolaringol; 2008; (6):52-4. PubMed ID: 19209416
    [No Abstract]   [Full Text] [Related]  

  • 2. [Betaserk in therapy of cochleovestibular disordes].
    Khrapko NS; Sedykh MI; As'kova LN; Tarasova NV; Velikanov AK; Baryshevskaia LA
    Vestn Otorinolaringol; 2006; (4):59-60. PubMed ID: 17152479
    [No Abstract]   [Full Text] [Related]  

  • 3. [Correction of autonomic sensory disorders in middle ear diseases].
    Morozova SV; Zaĭtseva OV
    Vestn Otorinolaringol; 2002; (3):38-41. PubMed ID: 12227028
    [No Abstract]   [Full Text] [Related]  

  • 4. [Betaserk efficiency in cochlear and vestibular disorders in the regional surdocenter].
    Pekaskiĭ SI
    Vestn Otorinolaringol; 2001; (3):61. PubMed ID: 11510053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of betaserk in patients with cochlear-vestibular disorders].
    Kadymov MI; Poliakova TS; Vladimirova TN
    Vestn Otorinolaringol; 1998; (5):49-50. PubMed ID: 9793432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological correction of cochleovestibular impairments].
    Pal'chun VT; Poliakova TS; Kunel'skaia NA; Bogdanets SA
    Vestn Otorinolaringol; 2004; (4):36-9. PubMed ID: 15496841
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic policy in cochleovestibular disorders in the presence of cerebral circulatory insufficiency].
    Kunel'skaia NL; Kamchatnov PR; Gulieva AE
    Vestn Otorinolaringol; 2008; (1):47-50. PubMed ID: 18454057
    [No Abstract]   [Full Text] [Related]  

  • 8. [Betaserc in the treatment of vestibular dysfunctions of different etiology].
    Nalimova TA; Kolenova IE
    Vestn Otorinolaringol; 2006; (1):57-8. PubMed ID: 16482015
    [No Abstract]   [Full Text] [Related]  

  • 9. Otosyphilis: diagnostic and therapeutic update.
    Linstrom CJ; Gleich LL
    J Otolaryngol; 1993 Dec; 22(6):401-8. PubMed ID: 8158733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The estimation of the efficacy of manual therapy included in the combined treatment of cochlear-vestibular disorders based on the results of computed stabilography].
    Shempeleva AÉ; Lopatin AS; Morozova SV; Gridin LA
    Vestn Otorinolaringol; 2012; (2):45-8. PubMed ID: 22810637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cavinton in the treatment of cochleovestibular disorders of vascular genesis].
    Kunel'skaia NL; Gulieva AE; Ianiushkina ES; Chugunova MI
    Vestn Otorinolaringol; 2009; (5):52-4. PubMed ID: 20041504
    [No Abstract]   [Full Text] [Related]  

  • 12. [Psychosomatic status of patients with cochleovestibular disorders. Correction methods].
    Pal'chun VT; Kunel'skaia NL; Krasiuk AA; Levina IuV
    Vestn Otorinolaringol; 2005; (6):21-4. PubMed ID: 16353003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic and treatment of the vestibular apparatus diseases in the climacteric patients].
    Moshev P; Dzgeljazkova Z; Benchev P
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():38-40. PubMed ID: 19496454
    [No Abstract]   [Full Text] [Related]  

  • 14. [The role of betaserk in combined treatment of neurosensory hypoacusis and vestibulopathy in childhood].
    Chistiakova VR
    Vestn Otorinolaringol; 2004; (2):9-12. PubMed ID: 15111941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Betahistine in the treatment of vestibular and coordination disturbances in multiple sclerosis].
    Popova NF; Chugunova MA; Kunel'skaia NL; Shagaev AS; Boĭko AN; Gusev EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2 Pt 2):77-81. PubMed ID: 21916160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of monotreane in the treatment of patients with cochleovestibular disorders].
    Pal'chun VT; Kadymova MI; Kriukov AI
    Vestn Otorinolaringol; 1989; (5):20-2. PubMed ID: 2588407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate management of immune-mediated cochleovestibular disorders.
    Sismanis A; Wise CM; Johnson GD
    Otolaryngol Head Neck Surg; 1997 Feb; 116(2):146-52. PubMed ID: 9051055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early small bowel perforation and cochleovestibular impairment as rare complications of typhoid fever.
    van Wolfswinkel ME; Lahri H; Wismans PJ; Petit PL; van Genderen PJ
    Travel Med Infect Dis; 2009 Sep; 7(5):265-8. PubMed ID: 19747660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of effectiveness of treatment of cochleovestibular disorders with mildronate].
    Luchikhin LA; Pankova TB; Kakymov MI
    Vestn Otorinolaringol; 1991; (2):36-40. PubMed ID: 2048251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Trimetazidine therapy in atrio-cochlear disturbances of vascular origin].
    Kozakiewicz K; Wróbel M; Petelenz T; Lepkowski A; Skrzypek-Wańha J; Chruściel TL
    Pol Tyg Lek; 1993 Apr 5-12; 48(14-15):327-9. PubMed ID: 8415248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.